title: [The European Union and drugs].
abstract: 1993 is a mythical year for the European Union which symbolizes at once the Achievement of the Internal market and the entry into force of Treaties of Policy and Economic Union. The European Union makes up, in all respects, a New Deal for Medicinal Products. Indeed, the scientific and technical harmonization is realized now at international level (ICH); the broader community competencies in the fields of Research, Industrial Policy and Environment predict a new positive context for innovation industry and competition probably in accordance with the European Agency. A contrario, the recognition of competences of Member States due to subsidiary in the following matters: Public Health, Social Security allow some flexibility in the interests of consumers, differences being explained by social and cultural behaviour in each Member State.
authors.affiliation: UFR de Pharmacie, Aix-Marseille II.
authors.forename: G
authors.initials: G
authors.lastname: Viala
authors.forename: M D
authors.initials: MD
authors.lastname: Campion
mesh_terms: D004345:Drug Industry / Q000191:economics; D005062:European Union; D004364:Pharmaceutical Preparations / Q000191:economics*; D011634:Public Health
chemical_list: D004364:Pharmaceutical Preparations
vernacular_title: L'Union Européenne et le médicament.